VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules
NCT03970993
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
BIOLOGICAL:
R21 Matrix-M vaccination
BIOLOGICAL:
R21 Matrix-M vaccination and CHMI
BIOLOGICAL:
R21 Matrix-M vaccination booster
Sponsor
University of Oxford